Cartesian Therapeutics (RNAC) Interest Coverage Ratio Growth (3y) (2018 - 2026)
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Interest Coverage Ratio Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -35.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 81.16% |
| 10 | Cartesian Therapeutics | 271.98 Mn | 271.98 Mn | - | -11.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.35% |
| Sep 30, 2023 | 35.15% |
| Jun 30, 2023 | 32.29% |
| Mar 31, 2023 | 30.90% |
| Dec 31, 2022 | 34.53% |
| Sep 30, 2022 | 59.67% |
| Jun 30, 2022 | 35.31% |
| Mar 31, 2022 | 35.88% |
| Dec 31, 2021 | 29.19% |
| Sep 30, 2021 | 59.44% |
| Jun 30, 2021 | 26.25% |
| Mar 31, 2021 | 39.37% |
| Dec 31, 2020 | 40.91% |
| Sep 30, 2020 | 10.05% |
| Jun 30, 2020 | -11.96% |
| Mar 31, 2020 | -11.85% |
| Dec 31, 2019 | 4.47% |
| Sep 30, 2019 | -8.18% |
| Jun 30, 2019 | -25.27% |
| Mar 31, 2019 | -10.17% |